GLRI (GLRI) Stock Price & Analysis
GLRI (GLRI) rose 0.00% to USD 0 as of June 10, 2026 at 08:35 UTC, according to Nexqual real-time market data.
GLRI last closed at USD 0; the session ranged USD 0–0 on volume of 500 shares. Market capitalization is $3,111, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 08:35 UTC.
Key Statistics (as of June 10, 2026 at 08:35 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 500 shares |
| Market Cap | $3,111 |
| Exchange | PNK |
Technical Analysis (GLRI)
Nexqual's technical model rates GLRI "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 08:35 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (GLRI)
Wall Street analysts rate GLRI "None", per Nexqual as of June 10, 2026 at 08:35 UTC.
| Consensus Rating | None |
|---|
Earnings (GLRI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2015-09-30 | USD -0.1 vs est -0.11 ▲ beat |
| 2015-06-30 | USD -0.1 vs est -0.08 ▼ miss |
| 2015-03-31 | USD -0.1 vs est -0.09 ▼ miss |
| 2014-12-31 | USD -0.15 vs est -0.08 ▼ miss |
Source: Nexqual, June 10, 2026 at 08:35 UTC.
Financials & Fundamentals (GLRI)
| Total Revenue | $5.11M |
|---|---|
| Revenue Growth (YoY) | -44.90% |
| Gross Margin | -50.73% |
| Operating Margin | -184.25% |
| Profit Margin | +0.00% |
| ROE | -233.02% |
| Current Ratio | 0.28 |
| Total Cash | $1.72M |
| Total Debt | $9.96M |
| Free Cash Flow | $-3.97M |
Source: Nexqual, June 10, 2026 at 08:35 UTC.
Financial Health Score (GLRI)
Nexqual rates GLRI's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 08:35 UTC.
| Growth | Critical — Revenue -45% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $2M cash vs $10M debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -233%, ROA -23.4% |
Ownership (GLRI)
| Insider Ownership | +48.22% |
|---|---|
| Institutional Ownership | +12.79% |
| Shares Outstanding | 31.12M |
| Float | 11.03M |
| Short % of Float | +1.47% |
Source: Nexqual, June 10, 2026 at 08:35 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TLOG | TETRALOGIC PHARMACEUTICALS CORP | USD 0 | ▲ 0% |
| GBIM | GLOBEIMMUNE INC | USD 0 | ▲ 0% |
| ICLD | INTERCLOUD SYSTEMS INC | USD 0 | ▲ 0% |
| TWER | Towerstream Corp. | USD 0.03 | ▲ 0% |
| CAPN | Cayson Acquisition Corp | USD 11.03 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 08:35 UTC. This page is informational and not investment advice.